of the etfs listed here which has the best liquidity/volume

**Bottom line 📈:** Among the leveraged-healthcare ETFs you mentioned, **LABU dominates on liquidity**, trading roughly **1 million shares per day** over the last month—an order of magnitude higher than the others. CURE and PILL sit in a distant second/third place, RXL is thinly traded, and SICK shows virtually no volume at all. --- ### How the numbers stack up 🔍 ```reference [{"type":"table-json","data":{"application/vnd.aime.table.v2+json":{"columns":[{"index_name":"Ticker","key":"Ticker","type":"STR"},{"index_name":"Average Volume","key":"Average Volume","type":"DOUBLE"}],"datas":[{"Ticker":"LABU","Average Volume":"1044439.380952381"},{"Ticker":"PILL","Average Volume":"87303.38095238095"},{"Ticker":"CURE","Average Volume":"116355.85714285714"},{"Ticker":"RXL","Average Volume":"8947.42857142857"},{"Ticker":"SICK","Average Volume":""}]}}}] ``` * LABU: ~1.0 M shares/day * CURE: ~0.12 M shares/day * PILL: ~0.09 M shares/day * RXL: ~0.009 M shares/day (≈9 k) * SICK: no meaningful trading volume recorded over the period ### Why liquidity matters 1. **Tighter spreads & lower slippage.** LABU’s depth means your orders clear closer to the quoted price—crucial for leveraged ETFs whose returns can swing wildly intraday. 2. **Scalability.** If you plan to size up, LABU can absorb larger trades without moving the market. 3. **Risk control.** Thinly traded products (RXL, SICK) can gap unexpectedly, making it harder to respect your “low single-digit drawdown” tolerance. ### Quick perspective on the field • **LABU (3× Biotech Bull)** is popular with day-traders and swing traders, so its liquidity is consistently high. • **CURE & PILL** track broader healthcare but see far less activity; spreads widen noticeably outside peak hours. • **RXL & SICK** are so illiquid that even small orders can distort pricing—best avoided unless you have a very specific niche strategy. --- 🤔 **Next step:** Would you like to explore entry/exit timing for LABU—or alternative, less volatile vehicles that still give you healthcare exposure without exceeding your drawdown comfort zone? --- : Volume data for LABU, 2025-10-04 to 2025-11-03 (ID 1) : Volume data for PILL, same period (ID 2) : Volume data for CURE, same period (ID 3) : Volume data for RXL, same period (ID 4) : Volume query for SICK returned zero results (ID 5)